Yersinia pseudotuberculosis bacteraemia in a kidney transplant patient.
Van Zonneveld
Monika
M
Department of Internal Medicine, Section of Nephrology, University Hospital Rotterdam, The Netherlands. vanzonneveld@mdl.azr.nl
Droogh
Joep M
JM
Fieren
Marien W J A
MW
Gyssens
Inge C
IC
Van Gelder
Teun
T
Weimar
Willem
W
D000890:Anti-Infective Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000139:chemically induced* / Q000188:drug therapy; D002939:Ciprofloxacin / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation; D008171:Lung Diseases / Q000000981:diagnostic imaging / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects* / Q000031:analogs & derivatives; D011239:Prednisolone / Q000627:therapeutic use; D019233:Retreatment; D013158:Splenic Diseases / Q000000981:diagnostic imaging / Q000382:microbiology; D014057:Tomography, X-Ray Computed; D015012:Yersinia pseudotuberculosis Infections / Q000139:chemically induced* / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy
D000890:Anti-Infective Agents; D007166:Immunosuppressive Agents; D002939:Ciprofloxacin; D016572:Cyclosporine; D011239:Prednisolone; D009173:Mycophenolic Acid